Skip to content
Uncertainty Hangs over the Biotech Sector episode artwork

Jun 29, 2017 22 min

Uncertainty Hangs over the Biotech Sector

from The Bio Report Hosted by Levine Media Group

The lack of clarity over healthcare reform, changes to tax policy, and concerns about new pricing pressures are creating uncertainty over the future health of the biotech industry. EY, in its just released annual report on the industry, looks at the effect the growing uncertainty has had on the performance of the biotech companies and strategies for contending with what’s ahead. We spoke to Glen Giovannetti, Global Biotechnology Leader for EY, about the new Beyond Borders report, what the numbers tell us, and ongoing efforts for the industry to adapt to a healthcare world moving from volume to value.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Uncertainty Hangs over the Biotech Sector

0:00 22:52

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The Bio Report?

This episode is 22 minutes long.

When was this The Bio Report episode published?

This episode was published on June 29, 2017.

Can I download this The Bio Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.